nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—CYP2C8—Vismodegib—skin cancer	0.247	0.319	CbGbCtD
Torasemide—CYP2C19—Vismodegib—skin cancer	0.208	0.267	CbGbCtD
Torasemide—CYP2C9—Vismodegib—skin cancer	0.173	0.222	CbGbCtD
Torasemide—CYP2C8—Fluorouracil—skin cancer	0.0879	0.113	CbGbCtD
Torasemide—CYP2C9—Fluorouracil—skin cancer	0.0613	0.0789	CbGbCtD
Torasemide—Hyponatraemia—Vismodegib—skin cancer	0.00545	0.0244	CcSEcCtD
Torasemide—Dehydration—Vismodegib—skin cancer	0.00505	0.0226	CcSEcCtD
Torasemide—Hypokalaemia—Vismodegib—skin cancer	0.00494	0.0221	CcSEcCtD
Torasemide—Gout—Imiquimod—skin cancer	0.00422	0.0189	CcSEcCtD
Torasemide—Atrial fibrillation—Vemurafenib—skin cancer	0.00354	0.0159	CcSEcCtD
Torasemide—Arthritis—Vemurafenib—skin cancer	0.00345	0.0155	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00302	0.0135	CcSEcCtD
Torasemide—Atrial fibrillation—Imiquimod—skin cancer	0.00302	0.0135	CcSEcCtD
Torasemide—Arthritis—Imiquimod—skin cancer	0.00294	0.0132	CcSEcCtD
Torasemide—Arthralgia—Vismodegib—skin cancer	0.00278	0.0125	CcSEcCtD
Torasemide—Myalgia—Vismodegib—skin cancer	0.00278	0.0125	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00256	0.0115	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00243	0.0109	CcSEcCtD
Torasemide—Dyspepsia—Vismodegib—skin cancer	0.00235	0.0105	CcSEcCtD
Torasemide—Constipation—Vismodegib—skin cancer	0.00228	0.0102	CcSEcCtD
Torasemide—Pain—Vismodegib—skin cancer	0.00228	0.0102	CcSEcCtD
Torasemide—Erectile dysfunction—Imiquimod—skin cancer	0.00228	0.0102	CcSEcCtD
Torasemide—Erythema multiforme—Vemurafenib—skin cancer	0.00219	0.00983	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00219	0.00979	CcSEcCtD
Torasemide—Throat sore—Docetaxel—skin cancer	0.00218	0.00976	CcSEcCtD
Torasemide—Oropharyngeal discomfort—Docetaxel—skin cancer	0.00216	0.00968	CcSEcCtD
Torasemide—Arthritis—Bleomycin—skin cancer	0.00209	0.00937	CcSEcCtD
Torasemide—Haemoglobin—Imiquimod—skin cancer	0.00199	0.00891	CcSEcCtD
Torasemide—Rhinitis—Imiquimod—skin cancer	0.00198	0.00889	CcSEcCtD
Torasemide—Haemorrhage—Imiquimod—skin cancer	0.00198	0.00887	CcSEcCtD
Torasemide—Asthenia—Vismodegib—skin cancer	0.00191	0.00858	CcSEcCtD
Torasemide—Erythema multiforme—Imiquimod—skin cancer	0.00187	0.00838	CcSEcCtD
Torasemide—Diarrhoea—Vismodegib—skin cancer	0.00183	0.00818	CcSEcCtD
Torasemide—Thirst—Temozolomide—skin cancer	0.0018	0.00807	CcSEcCtD
Torasemide—Cough—Vemurafenib—skin cancer	0.00176	0.0079	CcSEcCtD
Torasemide—Oropharyngeal pain—Docetaxel—skin cancer	0.00173	0.00774	CcSEcCtD
Torasemide—Arthralgia—Vemurafenib—skin cancer	0.00172	0.00771	CcSEcCtD
Torasemide—Myalgia—Vemurafenib—skin cancer	0.00172	0.00771	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00171	0.00765	CcSEcCtD
Torasemide—Vomiting—Vismodegib—skin cancer	0.0017	0.0076	CcSEcCtD
Torasemide—Rash—Vismodegib—skin cancer	0.00168	0.00754	CcSEcCtD
Torasemide—Dermatitis—Vismodegib—skin cancer	0.00168	0.00753	CcSEcCtD
Torasemide—Dehydration—Temozolomide—skin cancer	0.00159	0.00714	CcSEcCtD
Torasemide—Nausea—Vismodegib—skin cancer	0.00159	0.0071	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00158	0.00708	CcSEcCtD
Torasemide—Angioedema—Imiquimod—skin cancer	0.00157	0.00705	CcSEcCtD
Torasemide—Hypokalaemia—Temozolomide—skin cancer	0.00156	0.00699	CcSEcCtD
Torasemide—Syncope—Imiquimod—skin cancer	0.00155	0.00692	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00154	0.00692	CcSEcCtD
Torasemide—Hypotension—Vemurafenib—skin cancer	0.00154	0.0069	CcSEcCtD
Torasemide—Loss of consciousness—Imiquimod—skin cancer	0.00151	0.00678	CcSEcCtD
Torasemide—Cough—Imiquimod—skin cancer	0.0015	0.00674	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.0015	0.00673	CcSEcCtD
Torasemide—Myalgia—Imiquimod—skin cancer	0.00147	0.00657	CcSEcCtD
Torasemide—Arthralgia—Imiquimod—skin cancer	0.00147	0.00657	CcSEcCtD
Torasemide—Chest pain—Imiquimod—skin cancer	0.00147	0.00657	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00145	0.00649	CcSEcCtD
Torasemide—Haemoglobin—Bleomycin—skin cancer	0.00141	0.00633	CcSEcCtD
Torasemide—Constipation—Vemurafenib—skin cancer	0.00141	0.00632	CcSEcCtD
Torasemide—Oedema—Imiquimod—skin cancer	0.00141	0.0063	CcSEcCtD
Torasemide—Haemorrhage—Bleomycin—skin cancer	0.00141	0.0063	CcSEcCtD
Torasemide—Shock—Imiquimod—skin cancer	0.00138	0.0062	CcSEcCtD
Torasemide—Erectile dysfunction—Temozolomide—skin cancer	0.00136	0.00611	CcSEcCtD
Torasemide—Hyperglycaemia—Temozolomide—skin cancer	0.00134	0.00599	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00131	0.00587	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00128	0.00574	CcSEcCtD
Torasemide—Insomnia—Imiquimod—skin cancer	0.00127	0.0057	CcSEcCtD
Torasemide—Erythema multiforme—Dactinomycin—skin cancer	0.00124	0.00555	CcSEcCtD
Torasemide—Dyspepsia—Imiquimod—skin cancer	0.00124	0.00554	CcSEcCtD
Torasemide—Atrial fibrillation—Docetaxel—skin cancer	0.0012	0.00539	CcSEcCtD
Torasemide—Pain—Imiquimod—skin cancer	0.0012	0.00539	CcSEcCtD
Torasemide—Haemoglobin—Temozolomide—skin cancer	0.00119	0.00534	CcSEcCtD
Torasemide—Haemorrhage—Temozolomide—skin cancer	0.00119	0.00531	CcSEcCtD
Torasemide—Asthenia—Vemurafenib—skin cancer	0.00118	0.0053	CcSEcCtD
Torasemide—Hyponatraemia—Docetaxel—skin cancer	0.00114	0.00513	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00114	0.00511	CcSEcCtD
Torasemide—Diarrhoea—Vemurafenib—skin cancer	0.00113	0.00505	CcSEcCtD
Torasemide—Erythema multiforme—Temozolomide—skin cancer	0.00112	0.00502	CcSEcCtD
Torasemide—Haemoglobin—Fluorouracil—skin cancer	0.0011	0.00492	CcSEcCtD
Torasemide—Leukopenia—Bleomycin—skin cancer	0.0011	0.00491	CcSEcCtD
Torasemide—Rhinitis—Fluorouracil—skin cancer	0.0011	0.00491	CcSEcCtD
Torasemide—Haemorrhage—Fluorouracil—skin cancer	0.00109	0.0049	CcSEcCtD
Torasemide—Dizziness—Vemurafenib—skin cancer	0.00109	0.00488	CcSEcCtD
Torasemide—Cough—Bleomycin—skin cancer	0.00107	0.00478	CcSEcCtD
Torasemide—Dehydration—Docetaxel—skin cancer	0.00106	0.00475	CcSEcCtD
Torasemide—Vomiting—Vemurafenib—skin cancer	0.00105	0.0047	CcSEcCtD
Torasemide—Chest pain—Bleomycin—skin cancer	0.00104	0.00467	CcSEcCtD
Torasemide—Myalgia—Bleomycin—skin cancer	0.00104	0.00467	CcSEcCtD
Torasemide—Rash—Vemurafenib—skin cancer	0.00104	0.00466	CcSEcCtD
Torasemide—Dermatitis—Vemurafenib—skin cancer	0.00104	0.00465	CcSEcCtD
Torasemide—Headache—Vemurafenib—skin cancer	0.00103	0.00463	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00103	0.0046	CcSEcCtD
Torasemide—Leukopenia—Dactinomycin—skin cancer	0.00102	0.00458	CcSEcCtD
Torasemide—Asthenia—Imiquimod—skin cancer	0.00101	0.00452	CcSEcCtD
Torasemide—Oedema—Bleomycin—skin cancer	0.000999	0.00448	CcSEcCtD
Torasemide—Nausea—Vemurafenib—skin cancer	0.000979	0.00439	CcSEcCtD
Torasemide—Thrombocytopenia—Bleomycin—skin cancer	0.000978	0.00438	CcSEcCtD
Torasemide—Myalgia—Dactinomycin—skin cancer	0.000972	0.00435	CcSEcCtD
Torasemide—Diarrhoea—Imiquimod—skin cancer	0.000962	0.00431	CcSEcCtD
Torasemide—Angioedema—Temozolomide—skin cancer	0.000943	0.00423	CcSEcCtD
Torasemide—Hypotension—Bleomycin—skin cancer	0.000933	0.00418	CcSEcCtD
Torasemide—Oedema—Dactinomycin—skin cancer	0.000932	0.00417	CcSEcCtD
Torasemide—Dizziness—Imiquimod—skin cancer	0.00093	0.00417	CcSEcCtD
Torasemide—Leukopenia—Temozolomide—skin cancer	0.000924	0.00414	CcSEcCtD
Torasemide—Thrombocytopenia—Dactinomycin—skin cancer	0.000912	0.00409	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00091	0.00408	CcSEcCtD
Torasemide—Cough—Temozolomide—skin cancer	0.000901	0.00404	CcSEcCtD
Torasemide—Vomiting—Imiquimod—skin cancer	0.000894	0.00401	CcSEcCtD
Torasemide—Rash—Imiquimod—skin cancer	0.000887	0.00397	CcSEcCtD
Torasemide—Dermatitis—Imiquimod—skin cancer	0.000886	0.00397	CcSEcCtD
Torasemide—Headache—Imiquimod—skin cancer	0.000881	0.00395	CcSEcCtD
Torasemide—Arthralgia—Temozolomide—skin cancer	0.000879	0.00394	CcSEcCtD
Torasemide—Myalgia—Temozolomide—skin cancer	0.000879	0.00394	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000871	0.0039	CcSEcCtD
Torasemide—Pain—Bleomycin—skin cancer	0.000854	0.00383	CcSEcCtD
Torasemide—Leukopenia—Fluorouracil—skin cancer	0.000852	0.00381	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000849	0.0038	CcSEcCtD
Torasemide—Oedema—Temozolomide—skin cancer	0.000843	0.00377	CcSEcCtD
Torasemide—Nausea—Imiquimod—skin cancer	0.000835	0.00374	CcSEcCtD
Torasemide—Thrombocytopenia—Temozolomide—skin cancer	0.000825	0.0037	CcSEcCtD
Torasemide—Chest pain—Fluorouracil—skin cancer	0.00081	0.00363	CcSEcCtD
Torasemide—Myalgia—Fluorouracil—skin cancer	0.00081	0.00363	CcSEcCtD
Torasemide—Pain—Dactinomycin—skin cancer	0.000797	0.00357	CcSEcCtD
Torasemide—Haemoglobin—Docetaxel—skin cancer	0.000793	0.00355	CcSEcCtD
Torasemide—Rhinitis—Docetaxel—skin cancer	0.000791	0.00354	CcSEcCtD
Torasemide—Haemorrhage—Docetaxel—skin cancer	0.000789	0.00353	CcSEcCtD
Torasemide—Oedema—Fluorouracil—skin cancer	0.000776	0.00348	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000768	0.00344	CcSEcCtD
Torasemide—Insomnia—Temozolomide—skin cancer	0.000762	0.00341	CcSEcCtD
Torasemide—Thrombocytopenia—Fluorouracil—skin cancer	0.00076	0.00341	CcSEcCtD
Torasemide—Erythema multiforme—Docetaxel—skin cancer	0.000746	0.00334	CcSEcCtD
Torasemide—Dyspepsia—Temozolomide—skin cancer	0.000742	0.00332	CcSEcCtD
Torasemide—Hypotension—Fluorouracil—skin cancer	0.000726	0.00325	CcSEcCtD
Torasemide—Pain—Temozolomide—skin cancer	0.000721	0.00323	CcSEcCtD
Torasemide—Constipation—Temozolomide—skin cancer	0.000721	0.00323	CcSEcCtD
Torasemide—Asthenia—Bleomycin—skin cancer	0.000717	0.00321	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000707	0.00317	CcSEcCtD
Torasemide—Insomnia—Fluorouracil—skin cancer	0.000702	0.00315	CcSEcCtD
Torasemide—Dyspepsia—Fluorouracil—skin cancer	0.000683	0.00306	CcSEcCtD
Torasemide—Asthenia—Dactinomycin—skin cancer	0.000668	0.00299	CcSEcCtD
Torasemide—Pain—Fluorouracil—skin cancer	0.000664	0.00297	CcSEcCtD
Torasemide—Diarrhoea—Dactinomycin—skin cancer	0.000637	0.00286	CcSEcCtD
Torasemide—Vomiting—Bleomycin—skin cancer	0.000635	0.00285	CcSEcCtD
Torasemide—Rash—Bleomycin—skin cancer	0.00063	0.00282	CcSEcCtD
Torasemide—Dermatitis—Bleomycin—skin cancer	0.000629	0.00282	CcSEcCtD
Torasemide—Syncope—Docetaxel—skin cancer	0.000616	0.00276	CcSEcCtD
Torasemide—Leukopenia—Docetaxel—skin cancer	0.000615	0.00275	CcSEcCtD
Torasemide—Asthenia—Temozolomide—skin cancer	0.000605	0.00271	CcSEcCtD
Torasemide—Loss of consciousness—Docetaxel—skin cancer	0.000604	0.0027	CcSEcCtD
Torasemide—Cough—Docetaxel—skin cancer	0.000599	0.00268	CcSEcCtD
Torasemide—Nausea—Bleomycin—skin cancer	0.000593	0.00266	CcSEcCtD
Torasemide—Vomiting—Dactinomycin—skin cancer	0.000592	0.00265	CcSEcCtD
Torasemide—Rash—Dactinomycin—skin cancer	0.000587	0.00263	CcSEcCtD
Torasemide—Arthralgia—Docetaxel—skin cancer	0.000585	0.00262	CcSEcCtD
Torasemide—Chest pain—Docetaxel—skin cancer	0.000585	0.00262	CcSEcCtD
Torasemide—Myalgia—Docetaxel—skin cancer	0.000585	0.00262	CcSEcCtD
Torasemide—Diarrhoea—Temozolomide—skin cancer	0.000577	0.00258	CcSEcCtD
Torasemide—Oedema—Docetaxel—skin cancer	0.00056	0.00251	CcSEcCtD
Torasemide—Dizziness—Temozolomide—skin cancer	0.000557	0.0025	CcSEcCtD
Torasemide—Nausea—Dactinomycin—skin cancer	0.000553	0.00248	CcSEcCtD
Torasemide—Shock—Docetaxel—skin cancer	0.000551	0.00247	CcSEcCtD
Torasemide—Thrombocytopenia—Docetaxel—skin cancer	0.000549	0.00246	CcSEcCtD
Torasemide—Vomiting—Temozolomide—skin cancer	0.000536	0.0024	CcSEcCtD
Torasemide—Rash—Temozolomide—skin cancer	0.000531	0.00238	CcSEcCtD
Torasemide—Diarrhoea—Fluorouracil—skin cancer	0.000531	0.00238	CcSEcCtD
Torasemide—Dermatitis—Temozolomide—skin cancer	0.000531	0.00238	CcSEcCtD
Torasemide—Headache—Temozolomide—skin cancer	0.000528	0.00236	CcSEcCtD
Torasemide—Hypotension—Docetaxel—skin cancer	0.000524	0.00235	CcSEcCtD
Torasemide—Dizziness—Fluorouracil—skin cancer	0.000513	0.0023	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000511	0.00229	CcSEcCtD
Torasemide—Insomnia—Docetaxel—skin cancer	0.000507	0.00227	CcSEcCtD
Torasemide—Nausea—Temozolomide—skin cancer	0.000501	0.00224	CcSEcCtD
Torasemide—Vomiting—Fluorouracil—skin cancer	0.000494	0.00221	CcSEcCtD
Torasemide—Dyspepsia—Docetaxel—skin cancer	0.000493	0.00221	CcSEcCtD
Torasemide—Rash—Fluorouracil—skin cancer	0.00049	0.00219	CcSEcCtD
Torasemide—Dermatitis—Fluorouracil—skin cancer	0.000489	0.00219	CcSEcCtD
Torasemide—Headache—Fluorouracil—skin cancer	0.000486	0.00218	CcSEcCtD
Torasemide—Pain—Docetaxel—skin cancer	0.000479	0.00215	CcSEcCtD
Torasemide—Constipation—Docetaxel—skin cancer	0.000479	0.00215	CcSEcCtD
Torasemide—Nausea—Fluorouracil—skin cancer	0.000461	0.00207	CcSEcCtD
Torasemide—Asthenia—Docetaxel—skin cancer	0.000402	0.0018	CcSEcCtD
Torasemide—Diarrhoea—Docetaxel—skin cancer	0.000383	0.00172	CcSEcCtD
Torasemide—Dizziness—Docetaxel—skin cancer	0.000371	0.00166	CcSEcCtD
Torasemide—Vomiting—Docetaxel—skin cancer	0.000356	0.0016	CcSEcCtD
Torasemide—Rash—Docetaxel—skin cancer	0.000353	0.00158	CcSEcCtD
Torasemide—Dermatitis—Docetaxel—skin cancer	0.000353	0.00158	CcSEcCtD
Torasemide—Headache—Docetaxel—skin cancer	0.000351	0.00157	CcSEcCtD
Torasemide—Nausea—Docetaxel—skin cancer	0.000333	0.00149	CcSEcCtD
